US Stock MarketDetailed Quotes

VIRX Viracta Therapeutics

Watchlist

0.211
-0.002-0.80%

Close Jan 7 16:00 ET

0.210
-0.001-0.43%

Post 16:34 ET

8.39MMarket Cap-0.19P/E (TTM)

Viracta Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viracta Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Viracta Therapeutics Earnings Reports

Viracta Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 16:36 ET

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 13, 2024 07:33 ET

Viracta Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14, 2024 16:12 ET

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 14, 2024 07:19 ET

Analyst Rating

Updated: Jan 7, 2025

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall